Crossref journal-article
Elsevier BV
Cancer Letters (78)
Bibliography

Hogarty, M. D. (2003). The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification. Cancer Letters, 197(1–2), 173–179.

Authors 1
  1. Michael D. Hogarty (first)
References 32 Referenced 49
  1. 10.1097/00043426-199709000-00004 / J. Ped. Hem. Oncl. / Infant cancer in the US: histology-specific incidence and trends, 1973–1992 by Gurney (1997)
  2. 10.1200/JCO.1999.17.7.2264 / J. Clin. Oncol. / Molecular biology of neuroblastoma by Maris (1999)
  3. {'key': '10.1016/S0304-3835(03)00103-4_BIB3', 'first-page': '4248', 'article-title': 'Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients', 'volume': '47', 'author': 'Brodeur', 'year': '1987', 'journal-title': 'Cancer Res.'} / Cancer Res. / Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients by Brodeur (1987)
  4. 10.1038/sj.onc.1203880 / Oncogene / Complementation of Myc-dependent cell proliferation by cDNA expression library screening by Nikiforov (2000)
  5. {'key': '10.1016/S0304-3835(03)00103-4_BIB5', 'first-page': '861', 'article-title': 'Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes', 'volume': '3', 'author': 'Sawai', 'year': '1991', 'journal-title': 'New Biol.'} / New Biol. / Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes by Sawai (1991)
  6. {'key': '10.1016/S0304-3835(03)00103-4_BIB6', 'first-page': '3823', 'article-title': 'The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells', 'volume': '57', 'author': 'Fulda', 'year': '1997', 'journal-title': 'Cancer Res.'} / Cancer Res. / The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells by Fulda (1997)
  7. 10.1038/sj.onc.1202727 / Oncogene / Mechanisms of apoptosis by c-Myc by Prendergast (1999)
  8. 10.1126/science.278.5341.1305 / Science / Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis by Hueber (1997)
  9. 10.1038/35077213 / Nature / Proliferation, cell cycle and apoptosis in cancer by Evan (2001)
  10. 10.1038/35037739 / Nature / Apoptosis in the nervous system by Yuan (2000)
  11. {'key': '10.1016/S0304-3835(03)00103-4_BIB11', 'first-page': '775', 'article-title': 'Therapeutic attack of hypoxic cells of solid tumours: presidential address', 'volume': '48', 'author': 'Sartorelli', 'year': '1988', 'journal-title': 'Cancer Res.'} / Cancer Res. / Therapeutic attack of hypoxic cells of solid tumours: presidential address by Sartorelli (1988)
  12. 10.1093/emboj/16.11.2985 / EMBOJ. / Targeted expression of NMYC causes neuroblastoma in transgenic mice by Weiss (1997)
  13. {'key': '10.1016/S0304-3835(03)00103-4_BIB13', 'first-page': '2483', 'article-title': 'Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma', 'volume': '60', 'author': 'Weiss', 'year': '2000', 'journal-title': 'Cancer Res.'} / Cancer Res. / Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma by Weiss (2000)
  14. 10.1101/gad.13.20.2658 / Genes Dev. / Disruption of the ARF-Mdm2-p53 tumour suppressor pathway in Myc-induced lymphomagenesis by Eischen (1999)
  15. {'key': '10.1016/S0304-3835(03)00103-4_BIB15', 'first-page': '4053', 'article-title': 'Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification', 'volume': '53', 'author': 'Imamura', 'year': '1993', 'journal-title': 'Cancer Res.'} / Cancer Res. / Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification by Imamura (1993)
  16. 10.1038/75007 / Nat. Med. / Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN by Teitz (2000)
  17. {'key': '10.1016/S0304-3835(03)00103-4_BIB17', 'first-page': '1314', 'article-title': 'Resistance to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression', 'volume': '61', 'author': 'Eggert', 'year': '2001', 'journal-title': 'Cancer Res.'} / Cancer Res. / Resistance to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression by Eggert (2001)
  18. {'key': '10.1016/S0304-3835(03)00103-4_BIB18', 'first-page': '1543', 'article-title': 'Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification', 'volume': '143', 'author': 'Castle', 'year': '1993', 'journal-title': 'Am. J. Pathol.'} / Am. J. Pathol. / Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification by Castle (1993)
  19. 10.1038/sj.cdd.4400693 / Cell Death Differ. / IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma by van Golen (2000)
  20. 10.1016/S0304-3835(01)00530-4 / Cancer Lett. / Trk receptor tyrosine kinases: a bridge between cancer and neural development by Nakagawara (2001)
  21. 10.1056/NEJM199601253340405 / N. Engl. J. Med. / Association between high levels of expression of the multidrug resistance-associated protein (MRP) gene and poor outcome in primary human neuroblastoma by Norris (1996)
  22. {'key': '10.1016/S0304-3835(03)00103-4_BIB22', 'first-page': '5396', 'article-title': 'Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy', 'volume': '58', 'author': 'Keshelava', 'year': '1998', 'journal-title': 'Cancer Res.'} / Cancer Res. / Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy by Keshelava (1998)
  23. 10.1006/bcmd.2000.0372 / Blood Cells Mol. Dis. / Bcl-2 mediates chemoresistance in matched pairs of primary E(mu)-myc lymphomas in vivo by Schmitt (2001)
  24. {'key': '10.1016/S0304-3835(03)00103-4_BIB24', 'first-page': '2157', 'article-title': 'Tumour-specific down-regulation of the tumour necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation', 'volume': '62', 'author': 'van Noesel', 'year': '2002', 'journal-title': 'Cancer Res.'} / Cancer Res. / Tumour-specific down-regulation of the tumour necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation by van Noesel (2002)
  25. {'key': '10.1016/S0304-3835(03)00103-4_BIB25', 'first-page': '155', 'article-title': 'Clinical significance of expression of neurotrophic factors and their receptors in neuroblastoma', 'volume': '385', 'author': 'Nakagawara', 'year': '1994', 'journal-title': 'Prog. Clin. Biol. Res.'} / Prog. Clin. Biol. Res. / Clinical significance of expression of neurotrophic factors and their receptors in neuroblastoma by Nakagawara (1994)
  26. {'key': '10.1016/S0304-3835(03)00103-4_BIB26', 'first-page': '5269', 'article-title': 'Absence of p53 gene mutations in primary neuroblastomas', 'volume': '53', 'author': 'Vogan', 'year': '1993', 'journal-title': 'Cancer Res.'} / Cancer Res. / Absence of p53 gene mutations in primary neuroblastomas by Vogan (1993)
  27. {'key': '10.1016/S0304-3835(03)00103-4_BIB27', 'first-page': '897', 'article-title': 'Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumours and cell lines', 'volume': '9', 'author': 'Kovalev', 'year': '1998', 'journal-title': 'Cell Growth Differ.'} / Cell Growth Differ. / Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumours and cell lines by Kovalev (1998)
  28. {'key': '10.1016/S0304-3835(03)00103-4_BIB28', 'first-page': '3481', 'article-title': 'p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease', 'volume': '7', 'author': 'Omura-Minamisawa', 'year': '2001', 'journal-title': 'Clin. Cancer Res.'} / Clin. Cancer Res. / p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease by Omura-Minamisawa (2001)
  29. 10.1038/sj.onc.1202232 / Oncogene / The p16 (CDKN2A) gene is involved in the growth of neuroblastoma cells and its expression is associated with prognosis of neuroblastoma patients by Takita (1998)
  30. 10.1002/1096-911X(20001201)35:6<559::AID-MPO14>3.0.CO;2-J / Med. Pediatr. Oncol. / BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification by Hogarty (2000)
  31. 10.1038/sj.onc.1205180 / Oncogene / Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumour cell lines with 1p36 LOH and amplified MYCN by Teitz (2002)
  32. 10.1038/sj.onc.1203358 / Oncogene / High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma by Islam (2000)
Dates
Type When
Created 22 years, 4 months ago (April 4, 2003, 6:06 p.m.)
Deposited 6 years, 5 months ago (March 24, 2019, 4:58 a.m.)
Indexed 1 month, 2 weeks ago (July 16, 2025, 8:57 a.m.)
Issued 22 years, 1 month ago (July 1, 2003)
Published 22 years, 1 month ago (July 1, 2003)
Published Print 22 years, 1 month ago (July 1, 2003)
Funders 0

None

@article{Hogarty_2003, title={The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification}, volume={197}, ISSN={0304-3835}, url={http://dx.doi.org/10.1016/s0304-3835(03)00103-4}, DOI={10.1016/s0304-3835(03)00103-4}, number={1–2}, journal={Cancer Letters}, publisher={Elsevier BV}, author={Hogarty, Michael D.}, year={2003}, month=jul, pages={173–179} }